- Thread starter
- #11
The last time Medicare thought they were going to cover an Alzheimer's drug, part B went up about 14%. Wonder if we can expect roughly the same increase? $187? Maybe not, but I could see a part B premium of $175.
Increased from $148.50 in 2021 to $170.10 in 2022, down to $164.90 for 2023
Aduhelm is not without its' issues. Sketchy approval process. Original price $56k soon dropped to $28k. Cleveland Clinic and VA declined to participate in trials due to side effects such as brain swelling and bleeds.
"With the 50 percent price drop of Aduhelm on January 1, there is a compelling basis for CMS to reexamine the previous recommendation," he said at the time.
HHS's decision comes after the Centers for Medicare and Medicaid Services (CMS) released a report that found the costs saved from lower than expected spending on Aduhelm could be passed to Medicare beneficiaries in 2023.
Last month, Medicare announced that it would be limiting coverage of Aduhelm to only include clinical trial patients. HHS did not mention this decision in its announcement, though it may have contributed to the lower than expected costs for Aduhelm, on top of Biogen lowering its price.
https://thehill.com/policy/healthca...-from-alzheimers-drug-to-be-lowered-next-year